EA202091349A1 - Способы культивирования клеток - Google Patents

Способы культивирования клеток

Info

Publication number
EA202091349A1
EA202091349A1 EA202091349A EA202091349A EA202091349A1 EA 202091349 A1 EA202091349 A1 EA 202091349A1 EA 202091349 A EA202091349 A EA 202091349A EA 202091349 A EA202091349 A EA 202091349A EA 202091349 A1 EA202091349 A1 EA 202091349A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
cell culture
cell cultivation
culture medium
heterogeneity
Prior art date
Application number
EA202091349A
Other languages
English (en)
Russian (ru)
Inventor
Валентин Шеваллье
Надин Кочановски
Летисия Мальфетт
Венсен Адольф Кароль Кол
Original Assignee
Юсб Биофарма Срл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60629439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA202091349(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Юсб Биофарма Срл filed Critical Юсб Биофарма Срл
Publication of EA202091349A1 publication Critical patent/EA202091349A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
EA202091349A 2017-12-01 2018-11-29 Способы культивирования клеток EA202091349A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17204978.5A EP3492582A1 (en) 2017-12-01 2017-12-01 Cell culture methods
PCT/EP2018/083010 WO2019106091A1 (en) 2017-12-01 2018-11-29 Cell culture methods

Publications (1)

Publication Number Publication Date
EA202091349A1 true EA202091349A1 (ru) 2020-08-20

Family

ID=60629439

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091349A EA202091349A1 (ru) 2017-12-01 2018-11-29 Способы культивирования клеток

Country Status (14)

Country Link
US (1) US11859203B2 (cg-RX-API-DMAC10.html)
EP (2) EP3492582A1 (cg-RX-API-DMAC10.html)
JP (1) JP7422072B2 (cg-RX-API-DMAC10.html)
KR (1) KR20200092348A (cg-RX-API-DMAC10.html)
CN (1) CN111417715B (cg-RX-API-DMAC10.html)
BR (1) BR112020010473A2 (cg-RX-API-DMAC10.html)
CA (1) CA3083680A1 (cg-RX-API-DMAC10.html)
EA (1) EA202091349A1 (cg-RX-API-DMAC10.html)
ES (1) ES2963653T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20231175T1 (cg-RX-API-DMAC10.html)
HU (1) HUE063812T2 (cg-RX-API-DMAC10.html)
PL (1) PL3717631T3 (cg-RX-API-DMAC10.html)
SG (1) SG11202004935UA (cg-RX-API-DMAC10.html)
WO (1) WO2019106091A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN112391350A (zh) * 2020-10-30 2021-02-23 北京双鹭药业股份有限公司 高效表达抗egfr单克隆抗体细胞的筛选培养方法
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
EP4166651A1 (en) 2021-10-18 2023-04-19 Evonik Operations GmbH Methods and composition to increase cellular glutathione level
WO2023067626A1 (en) * 2021-10-20 2023-04-27 Dr. Reddy's Laboratories Limited A cell culture process to produce an antibody composition
US20250163487A1 (en) * 2022-02-21 2025-05-22 Chugai Seiyaku Kabushiki Kaisha Perfusion culture method
WO2024024720A1 (ja) * 2022-07-25 2024-02-01 味の素株式会社 細胞培養用の培地

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
KR20010075000A (ko) * 1998-10-09 2001-08-09 에가시라 구니오 시스테인 유도체
KR20050070512A (ko) 2003-12-30 2005-07-07 삼성정밀화학 주식회사 재조합 단백질의 생산성을 증가시키는 무혈청 배지 및동물세포 배양방법
EP2500416A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
TW201516149A (zh) * 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
LT2563906T (lt) 2010-04-26 2018-02-26 Novartis Ag Cho ląstelių kultivavimo būdas
WO2013158275A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
BR112016027797A2 (pt) 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
SG11201809408SA (en) * 2016-04-28 2018-11-29 Merck Patent Gmbh Method for reducing the trisulfide level in proteins
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods

Also Published As

Publication number Publication date
KR20200092348A (ko) 2020-08-03
HUE063812T2 (hu) 2024-02-28
US11859203B2 (en) 2024-01-02
CN111417715B (zh) 2024-08-27
ES2963653T3 (es) 2024-04-01
SG11202004935UA (en) 2020-06-29
EP3717631B1 (en) 2023-08-30
WO2019106091A1 (en) 2019-06-06
JP2021503938A (ja) 2021-02-15
EP3717631A1 (en) 2020-10-07
JP7422072B2 (ja) 2024-01-25
EP3492582A1 (en) 2019-06-05
CN111417715A (zh) 2020-07-14
US20200308536A1 (en) 2020-10-01
CA3083680A1 (en) 2019-06-06
BR112020010473A2 (pt) 2020-11-24
EP3717631C0 (en) 2023-08-30
PL3717631T3 (pl) 2024-03-04
HRP20231175T1 (hr) 2024-01-19

Similar Documents

Publication Publication Date Title
BR112021025359A2 (pt) Composições de proteína anti-vegf e métodos para a produção das mesmas
MX2025003310A (es) Integracion dirigida de acidos nucleicos
EA201890137A1 (ru) Среда для культивирования клеток с добавлением таурина и способы применения
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
EA202091407A1 (ru) Состав бессывороточной среды для культивирования клеток и способы его применения
EA202190326A2 (ru) Не содержащая сыворотки среда для культивирования клеток
EA201492183A1 (ru) Клетки для получения рекомбинантной идуронат-2-сульфатазы
EA201791443A1 (ru) Естественные киллерные клетки и их применения
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
SG10201809152QA (en) Recombinant host cell for expressing proteins of interest
BR112016028512A8 (pt) método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante
PH12016502148A1 (en) Methods of microalgae cultivation for increased resource production
MX376623B (es) Cultivo celular metabolicamente optimizado.
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
MX2021000209A (es) Metodos y productos para transfeccion de celulas.
PL439808A1 (pl) Sposoby i kompozycje hodowli komórkowych do produkcji przeciwciał
MX373329B (es) Células eucariotas novedosas y métodos para la expresión recombinante de un producto de interés.
EA201691532A1 (ru) Сверхэкспрессия регуляторов пути n-гликозилирования для модуляции гликозилирования рекомбинантных белков
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
MX388475B (es) Selección de células pluripotentes para producir ratones hembra xy fértiles.
EA201992828A1 (ru) Способы культивирования клеток
EA202192893A1 (ru) Среда для культивирования эукариотических клеток
MX2017012223A (es) Metodo de produccion con iones de cobre controlados.
MX2015010887A (es) Formulaciones y metodos para aumentar la produccion de proteinas recombinantes.